medmix

medmix EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of medmix (MEDX.SW) as of Oct 29, 2026 is 27.40 M CHF. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 12.90 M CHF — a change of 112.40% (higher).

EBITDA

27.40 MCHF

YoY

112.40%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of medmix is 2025 27.40 M CHF. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of medmix was 2024 12.90 M CHF. It decreases by 112.40% higher compared to the previous year.

The medmix EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
62.90 M CHF
Jan 1, 2019
38.20 M CHF
Jan 1, 2020
18.10 M CHF
Jan 1, 2021
59.90 M CHF
Jan 1, 2022
19.60 M CHF
Jan 1, 2023
13.00 M CHF
Jan 1, 2024
12.90 M CHF
Jan 1, 2025
27.40 M CHF
The medmix EBITDA history
YEAREBITDAYoY
27.40 MCHF+112.40%
12.90 MCHF-0.77%
13.00 MCHF-33.67%
19.60 MCHF-67.28%
59.90 MCHF+230.94%
18.10 MCHF-52.62%
38.20 MCHF-39.27%
62.90 MCHF—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

medmix Stock analysis

What does medmix do? The medmix AG is a Swiss company that specializes in the production and distribution of medical products. The company was founded in 1995 and is headquartered in Rapperswil-Jona in the canton of St. Gallen. The company focuses on developing and selling customized products, but has also expanded to manufacturing standardized products. They offer a wide range of high-quality medical products in the fields of surgery, anesthesia, intensive care, pneumology, and endoscopy. The company's business model is based on manufacturing and selling medical products that meet the latest technical standards and highest quality requirements. They prioritize innovation and research to constantly improve and expand their product range. Some of their products include ventilation devices, gas analyzers, respiratory monitoring systems, anesthesia accessories, endoscopes, surgical instruments, and implants. The company places great value on the quality and technical characteristics of their products, regularly testing and developing them for functionality and safety compliance. medmix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about medmix stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of medmix is 27.40 M CHF in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of medmix changed from 12.90 M CHF to 27.40 M CHF, representing a 112.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) medmix since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CHF is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s medmix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — medmix

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — medmix